Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
- 1 September 2001
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 358 (9283), 718-723
- https://doi.org/10.1016/s0140-6736(01)05840-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsHepatology, 1999
- Influence of Human Immunodeficiency Virus Infection on Chronic Hepatitis B in Homosexual MenHepatology, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.The Journal of Infectious Diseases, 1998
- Two-year lamivudine therapy in chronic hepatitis B infection: Results of a placebo controlled multicentre study in AsiaGastroenterology, 1998
- Postliver Transplant Allograft Reinfection with a Lamivudine‐Resistant Strain of Hepatitis B Virus: Long Term Follow‐upCanadian Journal of Gastroenterology and Hepatology, 1998
- Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Progress on the control of hepatitis B infection through immunisation.Gut, 1993